US 2023/0405006 A1Published application

Combination pharmaceutical composition and treatment method

AssigneeCarna Biosciences, Inc.

InventorsShigeki KASHIMOTO, Masaaki SAWA

Life of this patent

Estimating the term…

Abstract

Provided is a novel cancer treatment means in which a reversible BTK inhibitor and immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and anti PD-1 antibody are combined.

Claims15

Dependent claims

A pharmaceutical composition for treating a cancer comprising a reversible BTK inhibitor and an immune checkpoint inhibitor in combination.

Dependencies are inferred from the claim text.

Facts

Application: 18/035,592Filed 11 Nov 2021
Priority: JP 2020-18953213 Nov 2020
Published: 21 Dec 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 31/495
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with two or more nitrogen atoms as the only ring…
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…
A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results